Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy

Inclusion Criteria: * Age of Subjects: Patients ≥ 22 years of age. * Gender of Subjects: Both males and females will be invited to participate. * Subjects with diabetes (A1C level ≥ 6.5). * Subjects must be willing and are able to comply with clinic visit, understand the study-related procedures/provisions, and provide signed informed consent. Exclusion Criteria: * Unable to understand the study, Our unable to or unwilling to sign the informed consent * Previously diagnosed with macular edema, any form of diabetic retinopathy, radiation retinopathy, or retinal vein occlusion * participants who are experiencing persistent vision loss, blurred vision, or other vision problems that should be evaluated by an eye care provider * subjects whose retinal images were used in training, validating, or developing the device * Currently participating in another investigational eye study or actively receiving investigational product for DR or DME. * A condition that, in the opinion of the investigator, would preclude participation in the study; * Contraindicated for imaging by fundus imaging systems used in the study because of hypersensitivity to light, recently underwent photodynamic therapy, or was taking medication that causes photosensitivity.